Medical Bulletin 03/October/2025 Anshika Mishra3 Oct 2025 3:00 PM ISTHere are the top medical news for the day:New Blood Test Predicts Liver Disease Risk a Decade in Advance: Study Finds A simple blood analysis can...
New Blood Test Predicts Liver Disease Risk a Decade in Advance: Study Finds Anshika Mishra3 Oct 2025 8:00 AM ISTA simple blood analysis can predict the risk of developing severe liver disease, according to a new study from Karolinska Institutet published in The...
FDA Approves Bumetanide Nasal Spray for Edema in Heart, Liver, and Kidney Disease Dr. Kamal Kant Kohli18 Sept 2025 8:30 PM ISTThe FDA has approved Enbumyst (bumetanide nasal spray) for treating edema linked to congestive heart failure, liver disease, and kidney disease,...
Tirzepatide- A novel therapeutic against metabolic dysfunction-associated steatotic liver disease, reports research Dr. Kamal Kant Kohli13 Sept 2025 9:15 AM ISTMetabolic dysfunction-associated steatohepatitis (MASLD) is a liver disease with complex pathogenesis, characterized by abnormal lipid accumulation...
Both AKI Stage 1A and 1B Increase Mortality in Cirrhosis, suggests study Dr Riya Dave31 Aug 2025 8:45 PM ISTResearchers have determined in a new study that even mild acute kidney injury (AKI) in cirrhosis stage 1A, greatly elevates mortality risk over no AKI...
Study reveals beneficial effects of diet and exercise on alcohol-related adverse liver health Dr. Kamal Kant Kohli28 Aug 2025 8:45 PM ISTA novel study investigating how physical activity and diet quality interact with different levels and patterns of alcohol consumption shows that...
Chitinase-3-like protein 1: A novel biomarker for liver disease diagnosis and management, finds study Dr. Kamal Kant Kohli24 Aug 2025 8:00 PM ISTThe identification of Chitinase-3-like protein 1 (CHI3L1) as a crucial biomarker in liver disease is revolutionizing how clinicians approach the...
Study Finds GLP-1 RAs May Lower Liver and Heart Complications in MASLD Patients with Diabetes Medha Baranwal19 Aug 2025 9:45 AM ISTUSA: A recent study published in Diabetes, Obesity and Metabolism has reported that the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs)...
GLP-1 RAs Lower Risk of Liver Damage and Death in Alcohol Use, reveals research Dr Riya Dave14 July 2025 9:15 AM ISTResearchers have determined in a new study that the glucagon-like peptide-1 receptor agonists (GLP-1 RAs) lower the risk of alcohol-related liver...
Mankind Pharma Gets CDSCO Panel Nod to Conduct Phase III Trial of Resmetirom Tablets Parthika Patel21 Jun 2025 11:45 AM ISTNew Delhi: The Subject Expert Committee (SEC) under the Gastroenterology and Hepatology division of the Central Drugs Standard Control Organisation...
Fatty liver-but not liver damage-common in type 2 diabetes, suggests study Dr. Kamal Kant Kohli20 Jun 2025 9:30 AM ISTSix out of ten people with type 2 diabetes had fatty liver in a new study from Linköping University. Of these, only a small percentage had developed...
Medical Bulletin 17/June/2025 Dr. Bhumika Maikhuri17 Jun 2025 3:00 PM ISTHere are the top medical bulletins for the day:Smarter, Cheaper, Faster AI Tool for Cancer Monitoring: Study FindsA team of scientists from the A*STAR...
